Financial Gravity Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Financial Gravity Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	-$116K	–	1447
2019 Q4	$116K	Hold	1	–	–	0.08%	265
2019 Q3	$0	Hold	1	–	–	﹤0.01%	1715
2019 Q2	$0	Hold	1	–	–	﹤0.01%	1853
2019 Q1	$0	Buy	+1	New	+$82	﹤0.01%	1645
2018 Q3	$0	Hold	2	–	–	﹤0.01%	1735
2018 Q2	$0	Buy	2 +1	+100%	+$86	﹤0.01%	1737
2018 Q1	$0	Buy	+1	New	+$81	﹤0.01%	1571

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Financial Gravity Asset Management's CBPO Position: Q1 2020 in Review

Financial Gravity Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 1 share — an estimated $116K sold.

Financial Gravity Asset Management first reported a position in CBPO in Q1 2018 and held it in 7 quarters. The position peaked at $116K in Q4 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

Financial Gravity Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Financial Gravity Asset Management sold 1 China Biologic Products Holdings, Inc. share in Q1 2020, an estimated $116K.
Financial Gravity Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2018 and held it in 7 quarters.
Financial Gravity Asset Management's China Biologic Products Holdings, Inc. position peaked at $116K in Q4 2019.
84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on Financial Gravity Asset Management's 13F filing for Q1 2020, filed 12 May 2020.